Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
321.7 INR | +0.44% | +1.50% | -18.60% |
May. 16 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
May. 16 | Transcript : Indoco Remedies Limited, Q4 2024 Earnings Call, May 16, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.60% | 354M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- German Health Authority Clears Indoco Remedies' Oral Solid Dosage Plant in India